TWST: When we spoke last year, Allscripts was pursuing the $1.3 billion acquisition of Eclipsys. Is that deal complete and how has it positioned the company in the marketplace?
Mr. Tullman: First of all, the merger is complete. The reason that we brought the companies together was because Eclipsys was a leader in acute care software used in the largest and most sophisticated hospitals in the world, including Columbia Presbyterian in New York City or the University of Kentucky or University Hospitals in Cleveland. These are all leaders around the country, and Eclipsys provided some of the best acute software on the market. Allscripts was the leader on the ambulatory side with our software. So in bringing the companies together, you are really bringing together the leaders in the acute and ambulatory space. That was really preparing for what we are seeing today, which is accountable care organization and the need to manage a patient across all the continuums of care, which include the acute, the hospital, ambulatory, physician's office and then even post acute, which is once you leave a hospital, if you can't go home, you go into post acute. We were able to create an organization with 180,000 physicians, 1,500 hospitals and 10,000 post-acute care organizations. This is what we think of as the beginning of a connected community of health that is going to help to transform health care.
TWST: You've spoken about that connected community in the past. Where is Allscripts today in the connected community of health?
